Detalhe da pesquisa
1.
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Br J Cancer
; 130(5): 777-787, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191609
2.
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.
BMC Cancer
; 21(1): 64, 2021 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446148
3.
Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen.
PLoS One
; 17(6): e0269399, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657983
4.
Vitamin D modulation and microRNAs in gastric cancer: prognostic and therapeutic role.
Transl Cancer Res
; 10(6): 3111-3127, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35116620
5.
Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data.
Sci Rep
; 11(1): 14321, 2021 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253805
6.
Dynamic perspective of the neutrophil-to-lymphocyte ratio in metastatic gastric cancer.
J BUON
; 26(5): 2131-2140, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34761627
7.
Do Clinical Trials Meet Current Care Needs? Views of Digestive Oncology Specialists in Galicia (Spain) Using the Delphi Method.
Healthcare (Basel)
; 9(6)2021 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34205026